226 related articles for article (PubMed ID: 21725128)
1. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.
Flaherty MP; Johnston PV; Rade JJ
J Invasive Cardiol; 2011 Jul; 23(7):300-4. PubMed ID: 21725128
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents.
Migliorini A; Valenti R; Parodi G; Marcucci R; Abbate R; Carrabba N; Gensini GF; Antoniucci D
Am J Cardiol; 2013 Dec; 112(12):1843-8. PubMed ID: 24063827
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
Trenk D; Stone GW; Gawaz M; Kastrati A; Angiolillo DJ; Müller U; Richardt G; Jakubowski JA; Neumann FJ
J Am Coll Cardiol; 2012 Jun; 59(24):2159-64. PubMed ID: 22520250
[TBL] [Abstract][Full Text] [Related]
4. Use of prasugrel in a patient with clopidogrel hypersensitivity.
Peppard SR; Held-Godgluck BM; Beddingfield R
Ann Pharmacother; 2011 Oct; 45(10):e54. PubMed ID: 21896923
[TBL] [Abstract][Full Text] [Related]
5. Failure of high-dose clopidogrel in recurrent stent thrombosis.
Li Y; Chan MY
Singapore Med J; 2012 Aug; 53(8):e166-8. PubMed ID: 22941145
[TBL] [Abstract][Full Text] [Related]
6. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel?
Wiviott SD
Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236
[TBL] [Abstract][Full Text] [Related]
7. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
8. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Yokoi H; Kimura T; Isshiki T; Ogawa H; Ikeda Y
Thromb Res; 2012 May; 129(5):623-8. PubMed ID: 22178576
[TBL] [Abstract][Full Text] [Related]
11. Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.
Barison A; de Carlo M; Bellini F; Capozza PF; Lunardini A; Petronio AS
Acute Card Care; 2011 Mar; 13(1):52-4. PubMed ID: 21323408
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
Mousa SA; Jeske WP; Fareed J
Clin Appl Thromb Hemost; 2010 Apr; 16(2):170-6. PubMed ID: 20299391
[TBL] [Abstract][Full Text] [Related]
13. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
Murray AT; Sederberg JH
Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
[TBL] [Abstract][Full Text] [Related]
15. Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.
Campo G; Valgimigli M; Carrescia C; Carletti R; Ferrari R
Clin Appl Thromb Hemost; 2010 Oct; 16(5):591-3. PubMed ID: 19520678
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.
Diehl P; Olivier C; Halscheid C; Helbing T; Bode C; Moser M
Basic Res Cardiol; 2010 May; 105(3):379-87. PubMed ID: 19943165
[TBL] [Abstract][Full Text] [Related]
17. Prasugrel: a critical comparison with clopidogrel.
Reinhart KM; White CM; Baker WL
Pharmacotherapy; 2009 Dec; 29(12):1441-51. PubMed ID: 19947804
[TBL] [Abstract][Full Text] [Related]
18. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
[TBL] [Abstract][Full Text] [Related]
20. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]